Back to All Events

PCSS Waiver Training

  • St. Charles Convention Center (Jr. Ballroom A) 1 Convention Center Plaza Saint Charles, MO, 63303 United States (map)

About the training: Medication assisted treatment waiver training is available for physicians, nurse practitioners, and physician assistants interested in seeking to apply for their waiver to prescribe buprenorphine in the treatment of opioid use disorders. To obtain the waiver to prescribe buprenorphine, providers are required to take eight hours of training. Following trainings, participants who have successfully completed the course, may apply to the Substance Abuse and Mental Health Services Administration (SAMHSA) to obtain the waiver. PCSS-MAT urges all those who complete the course to submit a Notice of Intent Form to SAMHSA to obtain a waiver to prescribe. The waiver must be completed online and a link to the online form will be provided to participants following the training.

PCSS-MAT has a comprehensive library of materials (many are designated for AMA PRA Category 1 Credit™) available at no cost created to give healthcare providers confidence in treating their patients more effectively. PCSS-MAT also has a no-cost clinical coaching/mentoring program to provide one-on-one clinical expertise for primary care providers.

-Residents may take the course and apply for their waiver when they receive their DEA license. They will need to maintain their certificate of completion following the training. -Nurse practitioners (NPs) and physician assistants (PAs) who take this 8-hour MAT waiver course will receive a certificate of completion and can apply it toward the 24- hour training requirement established by the Comprehensive Addiction and Recovery Act (CARA). For the additional 16 hours, PCSS-MAT is also providing NPs and PAs with the coursework FREE and together they meet the required training to be eligible to apply for the waiver to prescribe buprenorphine.


Register online now >>


Funding for this initiative was made possible (in part) by Providers’ Clinical Support System for Medication Assisted Treatment (5U79TI024697) from SAMHSA and Opioid STR. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.